Concepedia

James Goodrich

JG

Statistics

Publications

23

Citations

2.5K

H-Index

18

Active since

1990

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

Chelsea and Westminster Hospital

UNSW Sydney

Cornell University

James Goodrich is an author at Pfizer (United States) specializing in medicine, hiv, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1990–2016

23

Publications

23

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

Roy M. Gulick, Jacob Lalezari, James Goodrich et al. · New England Journal of Medicine · 2008 · 735 citations · Full text

Molecular and Clinical Epidemiology of CXCR4‐Using HIV‐1 in a Large Population of Antiretroviral‐Naive Individuals

Zabrina L. Brumme, James Goodrich, Howard Mayer et al. · The Journal of Infectious Diseases · 2005 · 269 citations · Full text

Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection

David A. Cooper, Jayvant Heera, James Goodrich et al. · The Journal of Infectious Diseases · 2010 · 265 citations

Itraconazole treatment of phaeohyphomycosis

P. K. Sharkey, John R. Graybill, Michael G. Rinaldi et al. · Journal of the American Academy of Dermatology · 1990 · 212 citations

, , +4

Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial

Amit N. Patel, Timothy D. Henry, Arshed A. Quyyumi et al. · The Lancet · 2016 · 168 citations

, , +8

Rows per page

1–5 of 23